Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives
Wolfgang Poller(Berlin-Brandenburger Centrum für Regenerative Therapien), Ulf Landmesser(Deutsches Herzzentrum der Charité), Thomas Thum(Medizinische Hochschule Hannover), Stefanie Dimmeler(Goethe University Frankfurt), Stefan Blankenberg(Universität Hamburg), Roger J. Hajjar(Boston Biomedical Research Institute), Benjamin Meder(Heidelberg University), Tanja Zeller(Universität Hamburg), Philipp Jakob(German Centre for Cardiovascular Research), Stéphane Heymans(Maastricht University Medical Centre), Stefan Engelhardt(Heidelberg University), Mahir Karakas(Universität Hamburg), Shinichi Nakagawa(Unknown), David M. Leistner(University of Salzburg), Christian Weber(Munich Cluster for Systems Neurology), Jan Haas(Heidelberg University)
Cited by 416
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k